A. Torres (Barcelona, Spain), D. Bouros (Alexandroupolis, Greece)
LSC 2013 abstract - Mast cells support rhinovirus but not respiratory syncytial virus replication and contribute to the pro-inflammatory response to rhinovirus E. J. Swindle, C. Blume, P. Collins, D. D. Metcalfe, S. T. Holgate, D. E. Davies (Southampton, United Kingdom; Bethesda, United States Of America)
| |
Simplifying IDSA/ATS pneumonia guidelines W. Salih, J. Chalmers, S. Schembri (Dundee, United Kingdom)
| |
TLR7 gene deficiency and early-life pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice G. Kaiko, Z. Loh, K. Spann, J. Lynch, A. Lalwani, S. Davidson, P. Foster, S. Phipps (Newcastle, Brisbane, Australia)
| |
Vapendavir significantly improves upper respiratory symptoms of naturally acquired rhinovirus infection in asthmatic adults: Results of a phase 2 clinical trial J. Matz (Baltimore, United States Of America)
| |
Type I interferons and IL-15 regulate antiviral cellular responses to rhinovirus infection A. Jayaraman, S. Johnston, N. Bartlett (London, United Kingdom)
| |
Role of the immunoregulatory microRNA miR-146a in the innate immune response to rhinovirus infection C. Bellinghausen, E. V. Beuken, E. F. M. Wouters, G. G. U. Rohde, F. R. Stassen (Maastricht, Netherlands)
| |
The efficacy and safety of new combined medicinal product in the treatment of influenza: The results of a multicenter randomized comparative clinical trial A. Averyanov, E. Andrianova (Moscow, Russian Federation)
| |